Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law FDA's Overreach on Compounded Peptides BPC 157: Experimental Peptide Creates Risk for Athletes